Login Register Cart 0
Generic placeholder image

CNS & Neurological Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5273
ISSN (Online): 1996-3181

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

Evaluating the Potential of Green Light Exposure on Nociception-A Mini Review

Author(s): Hammad Qaiser, Mohammad Uzair, Muhammad Arshad, Anessa Zafar and Shahid Bashir*

Volume 23, Issue 6, 2024

Published on: 15 June, 2023

Page: [675 - 679] Pages: 5

DOI: 10.2174/1871527322666230522105931

Price: $65

conference banner
Abstract

The capacity of animals to react to unpleasant stimuli that might endanger their integrity is known as nociception. Pharmacological treatments do not show satisfactory results in response to nociception. In the recent era, light therapy emerged as a potential non-pharmacological approach for treating various diseases, including seasonal affective disorders, migraine, pain, and others. Evaluating the potential of green light exposure on nociception involves studying its effects on different types of pain and pain-related conditions and determining the optimal exposure methods. This review provides the beneficial effects of green light on the reduction in the frequency of pain. The green light exposure on nociception changes the activity of pain-related genes and proteins in cells. This review could provide insights into the underlying mechanisms by which green light modulates pain. Overall, evaluating the potential of green light exposure on nociception requires a multidisciplinary approach and should consider the safety, efficacy, optimal dose, and duration of green light exposure and the type of pain. However, few studies have been reported so far; therefore, light therapy for treating migraines require more studies on animal models to provide precise results of light effects on nociception.

Keywords: Nociception, migraine, light therapy, green light, white light, pain.

Next »
Graphical Abstract

[1]
Dubin AE, Patapoutian A. Nociceptors: The sensors of the pain pathway. J Clin Invest 2010; 120(11): 3760-72.
[http://dx.doi.org/10.1172/JCI42843] [PMID: 21041958]
[2]
Le Bars D, Gozariu M, Cadden SW. Animal models of nociception. Pharmacol Rev 2001; 53(4): 597-652.
[PMID: 11734620]
[3]
Council NR. Pain in Research Animals. US: National Academies Press 2009.
[4]
Basbaum AI, Bautista DM, Scherrer G, Julius D. Cellular and molecular mechanisms of pain. Cell 2009; 139(2): 267-84.
[http://dx.doi.org/10.1016/j.cell.2009.09.028] [PMID: 19837031]
[5]
Raffaeli W, Arnaudo E. Pain as a disease: an overview. J Pain Res. 2017; 10: 2003-8.
[http://dx.doi.org/10.2147/JPR.S138864] [PMID: 28860855]
[6]
Reuss AM, Groos D, Scholl R, Schröter M, Maihöfner C. Bluelight treatment reduces spontaneous and evoked pain in a human experimental pain model. Pain Rep 2021; 6(4): e968.
[http://dx.doi.org/10.1097/PR9.0000000000000968] [PMID: 34901678]
[7]
Allen S. Seeking pain relief with fewer side effects. IEEE Pulse 2022; 13(2): 11-5.
[http://dx.doi.org/10.1109/MPULS.2022.3159065] [PMID: 35657916]
[8]
Khanna R, Patwardhan A, Yang X, et al. Development and characterization of an injury-free model of functional pain in rats by exposure to red light. J Pain 2019; 20(11): 1293-306.
[http://dx.doi.org/10.1016/j.jpain.2019.04.008] [PMID: 31054915]
[9]
Segal JP, Tresidder KA, Bhatt C, Gilron I, Ghasemlou N. Circadian control of pain and neuroinflammation. J Neurosci Res 2018; 96(6): 1002-20.
[http://dx.doi.org/10.1002/jnr.24150]
[10]
Corder G, Castro DC, Bruchas MR, Scherrer G. Endogenous and exogenous opioids in pain. Annu Rev Neurosci 2018; 41(1): 453-73.
[http://dx.doi.org/10.1146/annurev-neuro-080317-061522] [PMID: 29852083]
[11]
Blume C, Garbazza C, Spitschan M. Effects of light on human circadian rhythms, sleep and mood. Somnologie 2019; 23(3): 147-56.
[http://dx.doi.org/10.1007/s11818-019-00215-x]
[12]
Mure LS. Intrinsically photosensitive retinal ganglion cells of the human retina. Front Neurol 2021; 12: 636330.
[http://dx.doi.org/10.3389/fneur.2021.636330]
[13]
Takemura Y, Kido K, Kawana H, Yamamoto T, Sanuki T, Mukai Y. Effects of green color exposure on stress, anxiety, and pain during peripheral intravenous cannulation in dental patients requiring sedation. Int J Environ Res Public Health 2021; 18(11): 5939.
[http://dx.doi.org/10.3390/ijerph18115939] [PMID: 34205936]
[14]
Ibrahim MM, Patwardhan A, Gilbraith KB, et al. Long-lasting antinociceptive effects of green light in acute and chronic pain in rats. Pain 2017; 158(2): 347-60.
[http://dx.doi.org/10.1097/j.pain.0000000000000767] [PMID: 28092651]
[15]
Liu YL, Gong SY, Xia ST, et al. Light therapy: A new option for neurodegenerative diseases. Chin Med J 2021; 134(6): 634-45.
[http://dx.doi.org/10.1097/CM9.0000000000001301] [PMID: 33507006]
[16]
Chuah LYM, Chee MWL. Treatment of circadian rhythm sleep disorders with light. Ann Acad Med Singap 2008; 37(8): 669-76.
[http://dx.doi.org/10.47102/annals-acadmedsg.V37N8p669] [PMID: 18797560]
[17]
Campbell PD, Miller AM, Woesner ME. Bright light therapy: Seasonal affective disorder and beyond. Einstein J Biol Med 2017; 32: E13-25.
[PMID: 31528147]
[18]
Martin LF, Cheng K, Washington SM, Denton M, Goel V, Khandekar M. Green light exposure elicits anti-inflammation, endogenous opioid release and dampens synaptic potentiation to relieve post-surgical pain. J Pain 2022; 24(3): 509-29.
[PMID: 36283655]
[19]
Fritsch C, Stege H, Saalmann G, Goerz G, Ruzicka T, Krutmann J. Green light is effective and less painful than red light in photodynamic therapy of facial solar keratoses. Photodermatol Photoimmunol Photomed 1997; 13(5-6): 181-5.
[http://dx.doi.org/10.1111/j.1600-0781.1997.tb00226.x] [PMID: 9542754]
[20]
Martin LF, Moutal A, Cheng K, et al. Green light antinociceptive and reversal of thermal and mechanical hypersensitivity effects rely on endogenous opioid system stimulation. J Pain 2021; 22(12): 1646-56.
[http://dx.doi.org/10.1016/j.jpain.2021.05.006] [PMID: 34157406]
[21]
Noseda R, Bernstein CA, Nir RR, et al. Migraine photophobia originating in cone-driven retinal pathways. Brain 2016; 139(7): 1971-86.
[http://dx.doi.org/10.1093/brain/aww119] [PMID: 27190022]
[22]
Noseda R, Copenhagen D, Burstein R. Current understanding of photophobia, visual networks and headaches. Cephalalgia 2019; 39(13): 1623-34.
[http://dx.doi.org/10.1177/0333102418784750]
[23]
Martin LF, Patwardhan AM, Jain SV, et al. Evaluation of green light exposure on headache frequency and quality of life in migraine patients: A preliminary one-way cross-over clinical trial. Cephalalgia 2021; 41(2): 135-47.
[http://dx.doi.org/10.1177/0333102420956711] [PMID: 32903062]
[24]
Cheatle MD, Foster S, Pinkett A, Lesneski M, Qu D, Dhingra L. Assessing and managing sleep disturbance in patients with chronic pain. Anesthesiol Clin 2016; 34(2): 379-93.
[http://dx.doi.org/10.1016/j.anclin.2016.01.007] [PMID: 27208716]
[25]
Yang CP, Wang SJ. Sleep in patients with chronic migraine. Curr Pain Headache Rep 2017; 21(9): 39.
[http://dx.doi.org/10.1007/s11916-017-0641-9] [PMID: 28785964]
[26]
Brainard GC, Hanifin JP, Greeson JM, et al. Action spectrum for melatonin regulation in humans: Evidence for a novel circadian photoreceptor. J Neurosci 2001; 21(16): 6405-12.
[http://dx.doi.org/10.1523/JNEUROSCI.21-16-06405.2001] [PMID: 11487664]
[27]
Esaki Y, Kitajima T, Ito Y, et al. Wearing blue light-blocking glasses in the evening advances circadian rhythms in the patients with delayed sleep phase disorder: An open-label trial. Chronobiol Int 2016; 33(8): 1037-44.
[http://dx.doi.org/10.1080/07420528.2016.1194289] [PMID: 27322730]
[28]
Gomes CC, Preto S. Blue light: A blessing or a curse? Procedia Manuf 2015; 3: 4472-9.
[http://dx.doi.org/10.1016/j.promfg.2015.07.459]
[29]
Bakos RM, Bakos L, Ferlin E, Cestari T, Orlandini T, Rezende R, et al. Photodynamic therapy with delta-aminolevulinic acid for superficial keratinocytic neoplasms. An Bras Dermatol 2003; 78: 197-207.
[http://dx.doi.org/10.1590/S0365-05962003000200007]
[30]
Wilkins AJ, Haigh SM, Mahroo OA, Plant GT. Photophobia in migraine: A symptom cluster? Cephalalgia 2021; 41(11-12): 1240-8.
[http://dx.doi.org/10.1177/03331024211014633]
[31]
Benarroch EE. The melanopsin system: Phototransduction, projections, functions, and clinical implications. Neurology 2011; 76(16): 1422-7.
[http://dx.doi.org/10.1212/WNL.0b013e31821671a5] [PMID: 21502603]
[32]
Cheng K, Martin LF, Slepian MJ, Patwardhan AM, Ibrahim MM. Mechanisms and pathways of pain photobiomodulation: A narrative review. J Pain 2021; 22(7): 763-77.
[http://dx.doi.org/10.1016/j.jpain.2021.02.005] [PMID: 33636371]
[33]
Reichenberg A, Cederlöf M, McMillan A, et al. Discontinuity in the genetic and environmental causes of the intellectual disability spectrum. Proc Natl Acad Sci 2016; 113(4): 1098-103.
[http://dx.doi.org/10.1073/pnas.1508093112] [PMID: 26711998]
[34]
Cheng K, Martin LF, Calligaro H, Patwardhan A, Ibrahim MM. Case report: Green light exposure relieves chronic headache pain in a colorblind patient. Clin Med Insights Case Rep 2022; 15
[http://dx.doi.org/10.1177/11795476221125164] [PMID: 36159182]
[35]
Martin L, Porreca F, Mata EI, et al. Green light exposure improves pain and quality of life in fibromyalgia patients: A preliminary one-way crossover clinical trial. Pain Med 2021; 22(1): 118-30.
[http://dx.doi.org/10.1093/pm/pnaa329] [PMID: 33155057]
[36]
Stovner LJ, Linde M, Gravdahl GB, et al. A comparative study of candesartan versus propranolol for migraine prophylaxis: A randomised, triple-blind, placebo-controlled, double cross-over study. Cephalalgia 2014; 34(7): 523-32.
[http://dx.doi.org/10.1177/0333102413515348] [PMID: 24335848]
[37]
Dodick DW, Freitag F, Banks J, et al. Topiramate versus amitriptyline in migraine prevention: A 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs. Clin Ther 2009; 31(3): 542-59.
[http://dx.doi.org/10.1016/j.clinthera.2009.03.020] [PMID: 19393844]
[38]
Akhtar A. The role of anti-calcitonin gene-related peptide in migraine and its implication in developing countries: A reasonable option to consider despite higher cost. Cureus 2019; 11(6): e4796.
[http://dx.doi.org/10.7759/cureus.4796] [PMID: 31396466]
[39]
Hoggan RN, Subhash A, Blair S, et al. Thin-film optical notch filter spectacle coatings for the treatment of migraine and photophobia. J Clin Neurosci 2016; 28: 71-6.
[http://dx.doi.org/10.1016/j.jocn.2015.09.024] [PMID: 26935748]
[40]
Huntsman DD, Bulaj G. Healthy dwelling: Design of biophilic interior environments fostering self-care practices for people living with migraines, chronic pain, and depression. Int J Environ Res Public Health 2022; 19(4): 2248.
[http://dx.doi.org/10.3390/ijerph19042248] [PMID: 35206441]
[41]
Prato FS, Desjardins-Holmes D, Keenliside LD, McKay JC, Robertson JA, Thomas AW. Light alters nociceptive effects of magnetic field shielding in mice: Intensity and wavelength considerations. J R Soc Interface 2009; 6(30): 17-28.
[http://dx.doi.org/10.1098/rsif.2008.0156]

Rights & Permissions Print Cite
Article Metrics
27
2
Wayfinder Image
World Patient Safety Day
© 2024 Bentham Science Publishers | Privacy Policy